MISOOK JOO: Open Payments
NPI 1598011371 · EDMONDS, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,180 in 43 payments from 17 companies in 2025. Trend: 2023 $1,047 · 2024 $1,069 · 2025 $1,180
Food & beverage: $1,180
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $370 |
| GlaxoSmithKline, LLC. | 3 | $163 |
| Novo Nordisk Inc | 7 | $155 |
| Amgen Inc. | 2 | $70 |
| AstraZeneca Pharmaceuticals LP | 3 | $68 |
| Abbott Laboratories | 2 | $50 |
| Merck Sharp & Dohme LLC | 2 | $46 |
| Exact Sciences Corporation | 2 | $44 |
| Edwards Lifesciences Corporation | 1 | $28 |
| Azurity Pharmaceuticals, Inc. | 1 | $28 |
Products named: LINZESS, PENMENVY, CREON, FARXIGA, FREESTYLE LIBRE 3, Wegovy, OTEZLA, SHINGRIX.
Industry payments across WA — which companies pay providers there.
